Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients
NCT05432778
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
90
Enrollment
OTHER
Sponsor class
Conditions
CMV Viremia
Interventions
DRUG:
Letermovir Pill
Sponsor
University Medical Centre Ljubljana